Medication Adherence in Rheumatic Diseases
- Conditions
- Chronic Rheumatic Diseases
- Registration Number
- NCT06018350
- Lead Sponsor
- Duke University
- Brief Summary
The investigators will pilot test a clinician-led intervention to improve medication adherence in general rheumatology clinic across a spectrum of rheumatic diseases. The study will assess feasibility, acceptability, and fidelity, and explore signal for improved medication adherence.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 12
- all providers at Southpoint Rheumatology All patients with a rheumatic disease diagnosis currently prescribed at least one rheumatic medication will be included in the analysis
- new patients, those who are not prescribed any rheumatic disease medications, or do not have available pharmacy refill data
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Intervention Feasibility 4 weeks Percent of visits with EMR documentation of providers reviewing refills
- Secondary Outcome Measures
Name Time Method Change in medication adherence baseline, 6 months 90-day medication possession ratio at 6 months after the intervention visit compared to baseline
Acceptability 4 weeks Provider survey based on the Acceptability of Intervention Measure, scores range from 1-5, 5 is most acceptable
Acceptability, as measured by the percentage of patients who report a positive feeling after having an adherence conversation with their providers 4 weeks Patient survey will be administered after their provider visit
Fidelity 4 weeks Frequency of EMR documentation of completing the intervention components of reviewing pharmacy refills and using effective communication strategies
Trial Locations
- Locations (1)
Duke University
🇺🇸Durham, North Carolina, United States
Duke University🇺🇸Durham, North Carolina, United States